Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Biocon To Benefit After Eli Lilly Joins Novo Nordisk To Exit European Insulins Market

    1 day ago

    The Bengaluru-based drugmaker has approvals for biosimilar versions of Insulin Glargine, Insulin Aspart and Human Insulin.
    Click here to Read More
    Previous Article
    ‘Free Metro Rides, AI Surveillance, Digital Tickets’: Bengaluru Plans Major IPL 2026 Safety Overhaul
    Next Article
    Waaree Energies, Premier Energies Rated 'Buy' As Geojit Initiates Coverage — Check Target Prices

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment